Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Oct-22 4:06 PM View:  | Clackson Timothy P Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 30,840 | -- | -- | (100%) 30.84K to 0 | |
| 14-Oct-22 4:07 PM View: | Lesser Brian Andrew SVP, Commercial Officer | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 52,593 | -- | -- | (100%) 52.59K to 0 | |
| 14-Oct-22 4:01 PM View: | Ra Capital Management, LLC Director 10% Owner | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 9,018,900 | -- | -- | (100%) 9.02M to 0 | |
| 14-Oct-22 4:07 PM View: | Fanucci Marsha Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 59,782 | -- | -- | (100%) 59.78K to 0 | |
| 14-Oct-22 4:07 PM View: | Lee Frank D. President and CEO Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 201,436 | -- | -- | (100%) 201.44K to 0 | |
| 14-Oct-22 4:07 PM View: | Potts Jeannette See Remarks | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 47,358 | -- | -- | (100%) 47.36K to 0 | |
| 14-Oct-22 4:06 PM View: | Shegog Todd SVP, Chief Financial Officer | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 56,143 | -- | -- | (100%) 56.14K to 0 | |
| 14-Oct-22 4:07 PM View: | Frederick Wayne A.I. Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 7,250 | -- | -- | (100%) 7.25K to 0 | |
| 14-Oct-22 4:06 PM View: | Wiggans Thomas G Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 7,250 | -- | -- | (100%) 7.25K to 0 | |
| 14-Oct-22 4:06 PM View: | Wirth Peter Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 134,915 | -- | -- | (100%) 134.91K to 0 | |
| 14-Oct-22 4:07 PM View: | Molina Arturo Md Director | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 14-Oct-22 4:06 PM View: | Melian Agustin EVP, Research & Development | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 79,000 | -- | -- | (100%) 79.0K to 0 | |
| 14-Oct-22 4:06 PM View: | Bishop John E SVP, Chief Technology Officer | Forma Therapeutics Holdings... (FMTX) | 14-Oct-22 | Disposition (change in control) | 47,950 | -- | -- | (100%) 47.95K to 0 | |
| 12-Jul-22 4:24 PM View: | Melian Agustin EVP, Research & Development | Forma Therapeutics Holdings... (FMTX) | 11-Jul-22 | Grant | 79,000 | -- | -- | 100% 0 to 79.0K | |
| 09-Jun-22 5:37 PM View: | Frederick Wayne A.I. Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 164% 2.75K to 7.25K | |
| 09-Jun-22 5:34 PM View: | Wiggans Thomas G Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 164% 2.75K to 7.25K | |
| 09-Jun-22 5:35 PM View: | Vickers Selwyn M Md Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 164% 2.75K to 7.25K | |
| 09-Jun-22 5:31 PM View: | Fanucci Marsha Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 8% 55.28K to 59.78K | |
| 09-Jun-22 5:30 PM View: | Molina Arturo Md Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 82% 5.5K to 10.0K | |
| 09-Jun-22 5:33 PM View: | Wirth Peter Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 3% 130.41K to 134.91K | |
| 09-Jun-22 5:30 PM View: | Ra Capital Management, LLC Director 10% Owner | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant Duplicate | 4,500 | -- | -- | < 1% 9.01M to 9.02M | |
| 09-Jun-22 5:32 PM View: | Clackson Timothy P Director | Forma Therapeutics Holdings... (FMTX) | 08-Jun-22 | Grant | 4,500 | -- | -- | 17% 26.34K to 30.84K | |
| 14-Apr-22 6:10 PM View: | Kelly Patrick F. SVP, Chief Medical Officer | Forma Therapeutics Holdings... (FMTX) | 08-Apr-22 | Option Exercise | 15,000 | $5.05 | $75,750.00 | 17% 89.88K to 104.88K | |
| 02-Mar-22 5:10 PM View: | Potts Jeannette See Remarks | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 25,000 | -- | -- | 112% 22.36K to 47.36K | |
| 02-Mar-22 5:14 PM View: | Cook David N SVP, Chief Scientific Officer | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 25,000 | -- | -- | 152% 16.47K to 41.47K | |
| 02-Mar-22 5:17 PM View: | Lee Frank D. President and CEO Director | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 121,667 | -- | -- | 153% 79.77K to 201.44K | |
| 02-Mar-22 5:14 PM View: | Bishop John E SVP, Chief Technology Officer | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 25,950 | -- | -- | 118% 22.0K to 47.95K | |
| 02-Mar-22 5:11 PM View: | Shegog Todd SVP, Chief Financial Officer | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 33,330 | -- | -- | 146% 22.81K to 56.14K | |
| 02-Mar-22 5:12 PM View: | Kelly Patrick F. SVP, Chief Medical Officer | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 25,000 | -- | -- | 39% 64.88K to 89.88K | |
| 02-Mar-22 5:10 PM View: | Lesser Brian Andrew SVP, Commercial | Forma Therapeutics Holdings... (FMTX) | 28-Feb-22 | Grant | 25,000 | -- | -- | 142% 17.59K to 42.59K | |
| 25-Feb-22 5:01 PM View: | Potts Jeannette See Remarks | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 4,672 | $9.78 | $45,680.50 | (17%) 27.03K to 22.36K | |
| 25-Feb-22 5:04 PM View: | Shegog Todd SVP, Chief Financial Officer | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 5,687 | $9.78 | $55,604.60 | (20%) 28.5K to 22.81K | |
| 25-Feb-22 5:02 PM View: | Lesser Brian Andrew SVP, Commercial | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 3,837 | $9.78 | $37,516.30 | (18%) 21.43K to 17.59K | |
| 25-Feb-22 5:08 PM View: | Kelly Patrick F. SVP, Chief Medical Officer | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 5,245 | $9.78 | $51,283.00 | (7%) 70.13K to 64.88K | |
| 25-Feb-22 10:00 PM View: | Wadlinger Mary E. See Remarks | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 4,684 | $9.78 | $45,797.80 | (3%) 139.21K to 134.52K | |
| 25-Feb-22 10:00 PM View: | Cook David N SVP, Chief Scientific Officer | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 3,531 | $9.78 | $34,524.40 | (18%) 20.0K to 16.47K | |
| 25-Feb-22 5:08 PM View: | Lee Frank D. President and CEO Director | Forma Therapeutics Holdings... (FMTX) | 23-Feb-22 | Sale | 17,981 | $9.78 | $175,809.00 | (18%) 97.75K to 79.77K | |
| 13-Jan-22 4:22 PM View: | Molina Arturo Md Director | Forma Therapeutics Holdings... (FMTX) | 12-Jan-22 | Grant | 5,500 | -- | -- | 100% 0 to 5.5K | |
| 21-Jun-21 7:02 PM View: | Wirth Peter Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 2% 127.67K to 130.41K | |
| 21-Jun-21 7:01 PM View: | Kolchinsky Peter Director 10% Owner | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | < 1% 9.01M to 9.01M | |
| 21-Jun-21 7:04 PM View: | Clackson Timothy P Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 12% 23.59K to 26.34K | |
| 21-Jun-21 7:06 PM View: | Frederick Wayne A.I. Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 100% 0 to 2.75K | |
| 21-Jun-21 7:05 PM View: | Wiggans Thomas G Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 100% 0 to 2.75K | |
| 21-Jun-21 7:09 PM View: | Vickers Selwyn M Md Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 100% 0 to 2.75K | |
| 21-Jun-21 7:04 PM View: | Fanucci Marsha Director | Forma Therapeutics Holdings... (FMTX) | 17-Jun-21 | Grant | 2,750 | -- | -- | 5% 52.53K to 55.28K | |
| 15-Jun-21 4:15 PM View: | Bishop John E Chief Technology Officer | Forma Therapeutics Holdings... (FMTX) | 14-Jun-21 | Grant | 22,000 | -- | -- | 100% 0 to 22.0K | |
| 05-Apr-21 4:31 PM View: | Ra Capital Management, LLC Director 10% Owner | Forma Therapeutics Holdings... (FMTX) | 01-Apr-21 | Acquisition (other) | 542,018 | $28.02 | $15,187,300.00 | 6% 8.47M to 9.01M | |
| 02-Mar-21 8:34 PM View: | Potts Jeannette See Remarks | Forma Therapeutics Holdings... (FMTX) | 26-Feb-21 | Grant | 23,630 | -- | -- | 695% 3.4K to 27.03K | |
| 02-Mar-21 8:29 PM View: | Cook David N SVP, Chief Scientific Officer | Forma Therapeutics Holdings... (FMTX) | 26-Feb-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 02-Mar-21 8:23 PM View: | Lee Frank D. President and CEO Director | Forma Therapeutics Holdings... (FMTX) | 26-Feb-21 | Grant | 97,750 | -- | -- | 100% 0 to 97.75K |
